No variables were selected in common between the ER+ BRCA and PRAD models (Fig. 3a), whereas only one variable, gene NKAPL, was selected in common between the TNBC and PRAD models using this strategy (Fig. 3b). Here, NKAPL is linked to prostate adenocarcinoma.